ALL | acute lymphoblastic leukemia |
ASCT | allogenic stem cell transplantation |
B-NHL | B-cell non-Hodgkin lymphomas |
CAR | chimeric antigen receptor |
CLL | chronic lymphocytic leukemia |
ORR | objective response rates |
OS | overall survival |
R/R | relapsed or Refractory |
NHL | non-Hodgkin lymphoma |
NSG | NOD scid IL2Rgammanull |